Exhibit (a)(1)(iv)
FORM OF ANNOUNCEMENT EMAIL TO ELIGIBLE PARTICIPANTS
| | |
TO: | | [Participant] |
FROM: | | info@mail.infiniteequity.com |
SUBJECT: | | IMPORTANT NEWS: Launch of Option Exchange Program |
DATE: | | January 30, 2024 |
IMPORTANT NEWS - PLEASE READ IMMEDIATELY. SHOULD YOU CHOOSE TO PARTICIPATE IN THIS PROGRAM, YOU MUST TAKE ACTION BY 11:59 P.M., EASTERN TIME, ON FEBRUARY 27, 2024.
We are pleased to provide details of the previously announced option exchange program. As you hold eligible options to purchase Common Stock, we encourage you to carefully read the “Offer to Exchange Certain Outstanding Options to Purchase Common Stock for a Number of Replacement Options” as well as the other offering materials contained in the Schedule TO we filed with the Securities and Exchange Commission on January 30, 2024, all of which are available on the option exchange website at www.myoptionexchange.com. These materials will help you to understand the risks and benefits of our exchange program and the terms and conditions of the offer.
OPTION EXCHANGE PROGRAM INFORMATION & WEBSITE
Below you will find a basic outline of the program. Please take the time to educate yourself about the program by reviewing the resources on the option exchange program website. If you choose to participate, you can elect to do so through this website as well. To log into the website, please go to www.myoptionexchange.com. Click on “Register as New User”, set your password, and check your email for the authentication code. You must use your Aligos email address.
ELIGIBILITY
All employees and directors of Aligos and its subsidiaries who are resident in the United States or Switzerland and remain continuously employed or who remain in continuous service through February 28, 2024 (the “Replacement Option Grant Date”), are eligible to exchange options granted under the Company’s 2020 Incentive Award Plan (the “2020 Plan”) with exercise prices equal to or greater than the highest closing trading price of a share of Common Stock during the 52-week period ending on February 27, 2024 (the “Offer Expiration Date”), which, as of the date of this Offer, is $2.10 (such 52-week high closing trading price, the “Minimum Exercise Price”).
EXCHANGE DETAILS
Options will be exchanged for new options covering a lesser number of shares of our Common Stock (“Replacement Options”) than the option tendered for exchange. The “exchange ratio” represents the number of shares underlying an eligible option that you must surrender in order to receive one share underlying an a new option. Exchange ratios vary based on exercise price and remaining term of the eligible option, and the exchange ratios applicable to your eligible options are available on the option exchange website.
Additional key features of the new options will include:
| • | | Type of Option: Incentive stock options to the maximum extent permitted by applicable law, with any remainder constituting non-qualified stock options. |
| • | | Vesting Period: Replacement options will be subject to a new initial one-year vesting period from the Replacement Option Grant Date, which we currently expect to be February 28, 2024. Upon the first anniversary of the Replacement Option Grant Date, the portion of the Replacement Option corresponding to the portion of the surrendered eligible option that would have been vested as of such date shall vest, and any remaining unvested portion of the Replacement Option will vest on the same schedule that previously applied to the surrendered eligible option (i.e., in substantially equal installments on the remaining original vesting dates), subject to accelerated vesting upon certain terminations if provided for under the agreement governing the surrendered eligible option. |